AFG Fiduciary Services’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
LMFP
PR
AAS
WAM
RFM
MFS
SGH
EWM
LHWM
MWA
AFG Fiduciary Services's XBI Position: Q2 2026 in Review
AFG Fiduciary Services reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 25% in Q2 2026, selling an estimated $85K and leaving 1,856 shares worth $298K. The position accounts for 0.23% of the portfolio, ranked #51.
AFG Fiduciary Services first reported a position in XBI in Q4 2021 and has held it in 18 quarters since. The position peaked at $1.06M in Q4 2021. 179 funds tracked by Wall St. Rank hold XBI as of Q2 2026.
- AFG Fiduciary Services held 1,856 shares of State Street SPDR S&P Biotech ETF worth $298K as of Q2 2026.
- AFG Fiduciary Services sold 629 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $85K.
- State Street SPDR S&P Biotech ETF made up 0.23% of AFG Fiduciary Services's portfolio in Q2 2026, its #51 holding.
- AFG Fiduciary Services first reported a position in State Street SPDR S&P Biotech ETF in Q4 2021 and has held it in 18 quarters since.
- AFG Fiduciary Services's State Street SPDR S&P Biotech ETF position peaked at $1.06M in Q4 2021.
- 179 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.
Based on AFG Fiduciary Services's 13F filing for Q2 2026, filed 9 Jul 2026.